VNRX VolitionRX Limited
$0.31▼ -8.76%
Healthcare
Other
After hours
$0.31▲ +1.26%
Sep 11, 7:51 PM ET
Volume 1.04M
Avg Volume (10D) 3.39M
Key Metrics & Fundamentals
Market Cap
$5.86M
P/E Ratio
–
Div Yield
–%
52W Range
0.31 - 14.80
% vs 50 MA
-59.66%
% vs 200 MA
-90.09%
RSI-14
26.8
MACD Histogram
+0.0200
Beta (1Y vs SPY)
1.30
Free Cash Flow
-$5.16M
Gross Rev
$398,657
Gross Profit
$398,657
EBITDA
-$3.92M
COGS
–
Operating Exp
$4.60M
Operating Income
-$4.20M
EBIT
-$4.20M
Pretax Income
-$7.32M
Net Income
-$7.33M
EPS (Diluted)
-0.85
Price & Volume History
Loading chart…
Recent News
Volition Presents Early Stage I Solid Cancer Detection at the ESMO MAP Conference
PR Newswire · Sep 10, 2026 12:17 PM
Penny Stock VolitionRx Expands Addressable Markets With Key Diagnostic Validations
Benzinga · Aug 27, 2026 11:35 AM
VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution Across $27+ Billion Total Addressable Markets
PR Newswire · Aug 26, 2026 1:17 PM
Volition Announces Landmark Clinical Validation of Nu.Q® NETs Biomarker in Sepsis
PR Newswire · Aug 26, 2026 12:17 PM
Volition (VNRX) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 20, 2026 11:28 PM
VolitionRx Limited Q2 2026 Earnings Call Summary
Moby · Aug 14, 2026 12:30 PM
VolitionRX: Q2 Earnings Snapshot
Associated Press · Aug 13, 2026 9:32 PM
VolitionRx Limited Announces Second Quarter 2026 Financial Results and Business Update
PR Newswire · Aug 13, 2026 8:10 PM
Earnings To Watch: VolitionRX Ltd (VNRX) Q2 2026 -- GF Value Sees 3914% Upside
GuruFocus.com · Aug 13, 2026 1:24 PM
Volition Demonstrates Utility of Rapid, Point-of-Care Finger-Prick Test in Sepsis Patients
PR Newswire · Aug 12, 2026 12:17 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See VNRX's money flow as a full page
Social Sentiment
Avg +0.10 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.